Sterling Capital Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.9K Sell
123
-2
-2% -$182 ﹤0.01% 2500
2025
Q4
$16.3K Buy
125
+79
+172% +$10.8K ﹤0.01% 2343
2025
Q3
$4.96K Buy
46
+1
+2% +$109 ﹤0.01% 2764
2025
Q2
$4.15K Sell
45
-149
-77% -$11.7K ﹤0.01% 2612
2025
Q1
$17.2K Sell
194
-158
-45% -$13.7K ﹤0.01% 1698
2024
Q4
$27.1K Buy
352
+316
+878% +$22.1K ﹤0.01% 1786
2024
Q3
$1.53K Buy
+36
New +$1.22K ﹤0.01% 2323

Other funds holding WGS

Sterling Capital Management's WGS Position: Q1 2026 in Review

Sterling Capital Management reduced its GeneDx Holdings (WGS) stake by 1.6% in Q1 2026, selling an estimated $182 and leaving 123 shares worth $7.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2500.

Sterling Capital Management first reported a position in WGS in Q3 2024 and has held it in 7 quarters since. The position peaked at $27.1K in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Sterling Capital Management held 123 shares of GeneDx Holdings worth $7.9K as of Q1 2026.
  • Sterling Capital Management sold 2 GeneDx Holdings shares in Q1 2026, an estimated $182.
  • GeneDx Holdings made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2500 holding.
  • Sterling Capital Management first reported a position in GeneDx Holdings in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's GeneDx Holdings position peaked at $27.1K in Q4 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.